|
|
Volumn 16, Issue 3, 2015, Pages e108-
|
|
Nivolumab shows clinical activity in Hodgkin's lymphoma
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
MONOCLONAL ANTIBODY;
PROGRAMMED DEATH 1 RECEPTOR;
ANTAGONISTS AND INHIBITORS;
FEMALE;
HODGKIN DISEASE;
HUMAN;
IMMUNOTHERAPY;
MALE;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
FEMALE;
HODGKIN DISEASE;
HUMANS;
IMMUNOTHERAPY;
MALE;
PROGRAMMED CELL DEATH 1 RECEPTOR;
|
|
EID: 84929049532
PISSN: None
EISSN: 14745488
Source Type: Journal
DOI: 10.1016/S1470-2045(15)70024-0 Document Type: Note |
|
Times cited : (4)
|
|
References (0)
|